Introduction

The EFMC - ACSMEDI Medicinal Chemistry Frontiers is co-organised on a biennial basis, as a collaboration between the ACS (American Chemical Society) and the EFMC (European Federation for Medicinal Chemistry).

Frontiers in Medicinal Chemistry 2019 will be jointly organised by EFMC, ACS and the local Polish organiser: the Polish Society of Medicinal Chemistry.

The 2019 edition of the symposium will take place in Krakow, Poland, from June 10-13, 2019.

This biennial meeting is a key symposium in its field with traditionally around 300 participants, from industry and academia. The EFMC - ACSMEDI Medicinal Chemistry Frontiers Meeting attracts a highly targeted audience composed of experts in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, early toxicology, as well as chemical and pharmaceutical development. The scientific programme for this meeting will feature a plenary session, followed by sessions covering the latest advances in medicinal chemistry.

The Conference topics will include:

• Adding AI to the Drug Discovery Tool Box
• Advances in Protein Degradation Technologies
• Chemical Biology Tools & Target Engagement Technologies
• Genomics in Drug Discovery : Roles for Chemistry
• GPCRs : a Discovery Powerhouse
• Matrix Metallo-Proteinases
• Multi-Targeted Drugs
• Opioid, Pain, Endo-Cannabinoid
• Targeted Covalent Inhibitors

Discover who will be chairing the sessions here!

Deadlines

• Mar 14 2019
  Oral abstracts deadline

  
• Mar 14 2019
  Poster abstract deadline

  
• Mar 14 2019
  Early bird registration deadline

  

Useful links

• Further event details More information about the event

Speakers

• Dr Jadwiga HANDZLIK MEDICAL COLLEGE OF JAGIELLONIAN UNIVERSITY, Krakow, Poland
• Prof. Krzysztof PALCZEWSKI CASE WESTERN RESERVE UNIVERSITY, Cleveland, United States
• Prof. Aseem ANSARI UNIVERSITY OF WISCONSIN-MADISON, Madison, United States
• Dr Tjeerd BARF ACERTA PHARMA BV, Oss, Netherlands
• Dr Gonçalo BERNARDES INSTITUTO DE MEDICINA MOLECULAR, PORTUGAL , United Kingdom
• Prof. Maria Laura BOLOGNESI UNIVERSITY OF BOLOGNA, Bologna, Italy
• Prof. Alessio CIULLI UNIVERSITY OF DUNDEE, Dundee, United Kingdom
• Prof. Marcin DRAG WROCLAV UNIVERSITY OF TECHNOLOGY, Wroclaw, Poland
• Prof. Alessandra S. EUSTAQUIO UNIVERSITY OF ILLINOIS AT CHICAGO, Chicago, United States
• Prof. Rafael FRANCO UNIVERSITY OF BARCELONA, Barcelona, Spain
• Prof. Leszek KACZMAREK NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY, Warsaw, Poland
• Dr Uta LESSEL BOEHRINGER INGELHEIM, Biberach an der Riss, Germany
• Dr Mickael MOGEMARK ASTRAZENECA, Mölndal, Sweden
• Dr Marc NAZARE FMP, Berlin, Germany
• Prof. Huib OVAA LEIDEN UNIVERSITY MEDICAL CENTER, Leiden, Netherlands
• Prof. Christopher OVERALL UNIVERSITY OF BRITISH COLUMBIA, Vancouver, Canada
• Prof. Christopher J. SCHOFIELD UNIVERSITY OF OXFORD, Oxford, United Kingdom
• Dr Lothar SCHWINK SANOFI, Frankfurt Am Main, Germany
• Prof. Holger STARK HEINRICH HEINE UNIVERSITY DÜSSELDORF, Duesseldorf, Germany
• Prof. Katarzyna STAROWICZ-BUBAK INSTITUTE OF PHARMACOLOGY, POLISH ACADEMY OF SCIENCES, Poland
• Dr Chris TATE MRC LABORATORY OF MOLECULAR BIOLOGY, Cambridge, United Kingdom
• Prof. Edward TATE IMPERIAL COLLEGE LONDON, London, United Kingdom
• Prof. Mark WALLER SHANGHAI UNIVERSITY, Shanghai, China
• Dr Pat WALTERS RELAY THERAPEUTICS, Cambridge, United States
• Dr Michal WARCHOL ARDIGEN, Krakow, Poland

---

Venue

Jagiellonian University

Auditorium Maximum, Jagiellonian University, Krupnicza 33, Krakow, 31-123 , Poland

Organised by

LD Organisation

Contact information

Bernard Dacier
LD Organisation
+3210454777
Contact us by email

---